Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 7,439 |
| Receivables | 4,175 |
| Inventories | 807 |
| TOTAL | $12,488 |
| Non-Current Assets | |
| PPE Net | 1,601 |
| Intangibles | 4,772 |
| Other Non-Current Assets | 20 |
| TOTAL | $6,393 |
| Total Assets | $18,881 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 129 |
| Other current liabilities | 110 |
| TOTAL | $2,562 |
| Non-Current Liabilities | |
| Long Term Debt | 1,005 |
| Deferred Revenues | 382 |
| TOTAL | $1,302 |
| Total Liabilities | $3,864 |
| Shareholders' Equity | |
| Common Shares | 17,765 |
| Retained earnings | -3,962 |
| Other shareholders' equity | 1,214 |
| TOTAL | $15,017 |
| Total Liabilities And Equity | $18,881 |